Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer
ObjectivesLong-term follow-up of patients treated with trastuzumab largely focuses on those with reduced left ventricular ejection fraction (LVEF) on treatment completion. This study sought to evaluate the prevalence of cardiovascular risk factors, overt cardiovascular disease and cardiac imaging ab...
Saved in:
Published in | Heart (British Cardiac Society) Vol. 110; no. 9; pp. 650 - 656 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd and British Cardiovascular Society
16.12.2023
BMJ Publishing Group LTD BMJ Publishing Group |
Series | Original research |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!